Clinical Trial: Trial of Suvorexant for Sleep in Children With Autism
Study Status: Completed
Recruit Status: RECRUITING
Condition: Autism
Study Type: INTERVENTIONAL
Official Title: Randomized Placebo-Controlled Crossover Trial of Suvorexant for Sleep in Children With Autism
Brief Summary:
The purpose of this study is to examine the effect of suvorexant on sleep in children and adolescents with Autism Spectrum Disorder (ASD).Suvorexant is a selective, dual orexin receptor antagonist (DORA) used for the treatment of sleep onset difficulties and/or sleep maintenance.To accomplish this, the investigators will use a randomized double-blind placebo-controlled crossover 8-week study design to examine the effect of suvorexant on sleep physiology as assessed by polysomnography (PSG), actigraphy,…
Read more